Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Chemical Communications (Cambridge, England)|November 16, 2011
Synthesis of 1,2,3-triazole-fused heterocycles via Pd-catalyzed cyclization of 5-iodotriazolesJacqueline M Schulman, Adam A Friedman, Jane Panteleev, et al.Nature Reviews. Cancer|November 6, 2015
Precision medicine for cancer with next-generation functional diagnosticsAdam A Friedman, Anthony Letai, David E Fisher, et al.Cancer Discovery|September 15, 2023
Precision Oncology Comes of Age: Designing Best-in-Class Small Molecules by Integrating Two Decades of Advances in Chemistry, Target Biology, and Data ScienceDarrin D Stuart, Angel Guzman-Perez, Natasja Brooijmans, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 28, 2017
Feasibility of Ultra-High-Throughput Functional Screening of Melanoma Biopsies for Discovery of Novel Cancer Drug CombinationsAdam A Friedman, Yun Xia, Lorenzo Trippa, et al.Science Signaling|October 27, 2011
Proteomic and functional genomic landscape of receptor tyrosine kinase and ras to extracellular signal-regulated kinase signalingAdam A Friedman, George Tucker, Rohit Singh, et al.Plos One|July 1, 2024
Correction: Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination TreatmentAdam A Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, et al.Plos One|October 14, 2015
Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination TreatmentAdam A Friedman, Arnaud Amzallag, Iulian Pruteanu-Malinici, et al.Molecular Systems Biology|March 13, 2019
Genome-wide prediction of synthetic rescue mediators of resistance to targeted and immunotherapyAvinash Das Sahu, Joo S Lee, Zhiyong Wang, et al.Nature Communications|June 28, 2023
A landscape of response to drug combinations in non-small cell lung cancerNishanth Ulhas Nair, Patricia Greninger, Xiaohu Zhang, et al.Pageof 1